triazoles has been researched along with oxycodone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hagelberg, NM; Laine, K; Neuvonen, M; Neuvonen, PJ; Nieminen, TH; Olkkola, KT; Saari, TI | 2 |
| Chiba, S; Hara, A; Homma, M; Kohda, Y; Momo, K; Okoshi, Y; Wada, T; Watanabe, M | 1 |
| Hopfgartner, G; Le Blanc, JC; Varesio, E | 1 |
| Blough, BE; Freeman, KB; Pareek, T; Prisinzano, TE; Schrock, HM; Sufka, KJ; Zamarripa, CA | 1 |
| Blough, BE; Brasfield, M; Dunaway, K; Freeman, KB; Huskinson, SL; Platt, DM; Prisinzano, TE; Zamarripa, CA | 1 |
1 trial(s) available for triazoles and oxycodone
| Article | Year |
|---|---|
Voriconazole drastically increases exposure to oral oxycodone.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Antifungal Agents; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Male; Oxycodone; Pyrimidines; Triazoles; Voriconazole | 2009 |
5 other study(ies) available for triazoles and oxycodone
| Article | Year |
|---|---|
Interaction of oxycodone and voriconazole-a case series of patients with cancer pain supports the findings of randomised controlled studies with healthy subjects.
Topics: Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Female; Humans; Male; Oxycodone; Pyrimidines; Triazoles; Voriconazole | 2011 |
Effects of voriconazole co-administration on oxycodone-induced adverse events: a case in the retrospective survey.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Mycoses; Oxycodone; Pyrimidines; Receptors, Opioid, mu; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Real-time 2D separation by LC × differential ion mobility hyphenated to mass spectrometry.
Topics: Aminoquinolines; Benzimidazoles; Bromazepam; Chlorprothixene; Chromatography, High Pressure Liquid; Clonazepam; Fendiline; Humans; Mass Spectrometry; Oxycodone; Silanes; Time Factors; Triazoles | 2012 |
The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Male; Nociception; Oxycodone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Self Administration; Triazoles | 2021 |
The G-protein biased kappa opioid agonists, triazole 1.1 and nalfurafine, produce non-uniform behavioral effects in male rhesus monkeys.
Topics: Analgesics, Opioid; Animals; GTP-Binding Proteins; Hypnotics and Sedatives; Macaca mulatta; Male; Morphinans; Oxycodone; Receptors, Opioid, kappa; Spiro Compounds; Triazoles | 2022 |